Skip to content
Tuesday, March 19, 2024
Latest:
SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin
MindMed Announces Inclusion in FTSE Russell Indexes
Biotech Stock Market News
Know First, Act First
Cannabis & Cancer
General
Coronavirus
Financing & Fiscal
Shareholders